Edit
Wallonie Entreprendre
https://www.wallonie-entreprendre.be/Last activity: 27.02.2026
Probably Closed
Votre partenaire ! WE est l’outil économique et financier de la Wallonie au service des entreprises. Nous apportons les moyens nécessaires au développement de l’activité dans tous les secteurs. Nos investissements et financements répondent à une logique de création, de croissance, de transmission ou de relance des entreprises. Nous veillons au respect des normes sociales et environnementales. Nous prônons la durabilité et la circularité des démarches économiques. Ensemble, nous créons les futurs de la Wallonie.
Location: Belgium, Liège
Employees: 201-500
Founded date: 2002
Mentions in press and media 14
| Date | Title | Description |
| 27.02.2026 | Syndicate One Secures €22M: Belgian Tech Soars | Syndicate One closed its second fund at €22 million. This significant capital boost targets Belgian tech innovation. The network-driven firm empowers early-stage startups. It backs founders worldwide. Its portfolio boasts multiple success s... |
| 23.02.2026 | Syndicate One closes €22M second fund to back Belgian tech founders | Syndicate One, an international network-driven investment firm backing Belgian startup founders, has completed the first close of its second fund at €22 million. The fund was oversubscribed within eight weeks of the initial pitch, reflectin... |
| 23.02.2026 | Backing Belgium’s best: Brussels-based Syndicate One concludes €22 million first close of second fund | Brussels-based Syndicate One, an international network-driven fund backing technology startups based in Belgium or founded by Belgian entrepreneurs, today announced that it has concluded the first close of its second fund at €22 million. Th... |
| 11.01.2026 | Enodia Therapeutics Secures €20.7M Seed Funding to Pioneer Protein Degradation with AI | Enodia Therapeutics, a pioneering biotech firm, secured a significant €20.7 million ($25 million) seed funding round. This vital capital propels its innovative small-molecule platform, a breakthrough approach targeting protein degradation a... |
| 11.01.2026 | Enodia Therapeutics Raises €20.7M to Target "Undruggable" Proteins with SEC61 Platform | Enodia Therapeutics, a Paris-based biotech, has secured €20.7 million ($25 million) in seed funding. Argobio Studio launched the company. Enodia develops small molecules. Its platform targets protein degradation at the point of synthesis. I... |
| 10.01.2026 | Enodia Therapeutics: €20.7 Million Seed Funding Closed To Advance SEC61-Based Small-Molecule Protein Degradation Platform | Enodia Therapeutics has raised €20.7 million (about $25 million) in a seed financing to advance a discovery platform that uses proteomics and machine learning to develop small molecules that degrade disease-driving proteins at the point of ... |
| 09.01.2026 | Argobio Launches Enodia With €20.7 Million Seed Round To Develop Small Molecules For Protein Degradation | Argobio Studio announced it has launched Enodia Therapeutics and completed a €20.7 million ($25 million) seed financing to advance a small-molecule platform for targeted protein degradation at the point of protein synthesis, enabled by prot... |
| 08.01.2026 | Enodia Therapeutics Raises €20.7M in Seed Funding | Enodia Therapeutics, a Paris, France-based biotechnology company developing novel small-molecule therapies for targeted protein degradation at the point of synthesis, raised €20.7m (US$25m) in Seed financing. The round was co-led by Elaia, ... |
| 24.01.2025 | mi2-factory secures Series A financing and IPCEI ME/KT funding for novel EFIITRON semiconductor process technology | mi2-factory GmbH, a high-tech start-up in the field of semiconductor equipment, today announces the closing of a EUR 15 million Series A financing and the commitment of a government grant from the ICPEI ME/CT program of up to E... |
| 17.07.2024 | SamanTree Medical makes strategic changes after $14M round | From biopsy taking to surgical diagnosis, tissue assessment is a key component to efficient and straightforward cancer treatment. However, obtaining high-resolution results promptly remains a major challenge. SamanTree’s Histolog Scanner i... |
Show more